Analyst Ratings for BeiGene, Ltd. (BGNE)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/3/2024 | Morgan Stanley | Sean Laaman | New Coverage | Overweight (N/A) |
300.00 (N/A) |
205.75 (184.71) |
-10.23% | Details |
| 9/18/2024 | Citizens | Reni Benjamin | New Coverage | Market Outperform (N/A) |
288.00 (N/A) |
196.45 (184.71) |
-5.98% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
